Sarcio
Apple Valley, US · Founded 2020 · Minnesota corporation · 1 known investors
Find your way into Sarcio
55 people in our graph share verified history with the Sarcio team — schools, employers, funds. One of them is your warm intro.
Isaac Zikeunlockedknows Beth Lindborg · together at University of Minnesota (overlapped)
×7knows the team · via University of Minnesota
×3knows the team · via Carlson School of Management
knows the team · via Sarcio Inc.
Sarcio Inc. is a University of Minnesota Stem Cell Institute spin-out developing regenerative, disease-modifying therapeutics by isolating exosomes from iPSC-derived cartilage tissue to treat osteoarthritis and restore joint function. The company aims to delay or eliminate the need for joint-replacement surgery.
Founders & leadership
Sarcio was founded in 2020 by Timothy D. O'Brien.
TD
Timothy D. O'BrieninFounder & Chief Scientific Officer, DirectorTimothy D. O'Brien holds a Doctor of Veterinary Medicine and Doctor of Philosophy in Veterinary Pathology from the University of Minnesota-Twin Cities, and is board certified in veterinary anatomic pathology. He was a faculty member at the University of Minnesota Stem Cell Institute conducting research on organoid formation from human induced pluripotent stem cells for neurological disease modeling and cartilage repair therapeutics.
TO
Timothy O'BrieninChief Scientific Officer & DirectorTimothy O'Brien holds a DVM and PhD in veterinary pathology from the University of Minnesota and is board certified in veterinary anatomic pathology. He is Chief Scientific Officer and Director of Sarcio, a University of Minnesota Stem Cell Institute spin-out, and previously conducted research on organoid development from human induced pluripotent stem cells for applications in disease modeling and therapeutic cartilage repair.
AV
Amanda VegoeFounder & Chief Operations Officer
BL
Beth Lindborgin𝕏Founder & Chief Executive Officer, DirectorBeth Lindborg is founder and CEO of Sarcio, a University of Minnesota Stem Cell Institute spin-out developing exosome-based regenerative therapeutics derived from iPSC cartilage tissue to treat osteoarthritis.
MT
Marc TompkinsChief Medical Officer
MW
Michael WilliamsChief Business Officer
TD
Timothy D. O'Brien, DVM, PhD, DACVPFounder & Chief Scientific Officer, Director
Investors · 1
Reported raises · per SEC filings
Form D private placements$1.4M disclosed across 2 rounds · 2021
▶$785.3KraisedAug 2023 · 23 investors · BiotechnologyRule 506(b)
▶$785.3KraisedAug 2023 · 23 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Beth LindborgExecutive Officer, Director
- Michael WilliamsDirector
- Amanda VegoeExecutive Officer
- Marc TompkinsExecutive Officer
- Timothy O'BrienExecutive Officer, Director
- Offering amount
- $850K
- Amount sold
- $785.3K
- Proceeds to insiders
- $120K
- First sale
- Mar 2021
- Incorporated
- Corporation, Minnesota, 2020
- Federal exemptions
- 06b, 4a5
▶$607.5KraisedJul 2023 · 13 investors · BiotechnologyRule 506(b)
▶$607.5KraisedJul 2023 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Timothy O'BrienExecutive Officer, Director
- Amanda VegoeExecutive Officer
- Beth LindborgExecutive Officer, Director
- Marc TompkinsExecutive Officer
- Michael WilliamsDirector
- Offering amount
- $750K
- Amount sold
- $607.5K
- First sale
- Dec 2021
- Incorporated
- Corporation, Minnesota, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Sarcio do?
- Sarcio Inc. is a University of Minnesota Stem Cell Institute spin-out developing regenerative, disease-modifying therapeutics by isolating exosomes from iPSC-derived cartilage tissue to treat osteoarthritis and restore joint function. The company aims to delay or eliminate the need for joint-replacement surgery.
- Who founded Sarcio?
- Sarcio was founded by Timothy D. O'Brien in 2020.
- Who are Sarcio's investors?
- Sarcio's investors include GROOVE CAPITAL.
- How much funding has Sarcio raised?
- Sarcio has disclosed $1.4M raised across 2 rounds.
- Where is Sarcio headquartered?
- Sarcio is headquartered in Apple Valley, US.